EQS-News: Lonza Group AG: Lonza Completes Divestment of Specialty Ingredients Business
Lonza Completes Divestment of Specialty Ingredients Business
02.07.2021 / 07:00
Basel, Switzerland, 2 July 2021 -
Lonza announced today the completion of the divestment of its former Specialty Ingredients business and operations to Bain Capital and Cinven for an enterprise value of CHF 4.2 billion.
Albert M. Baehny, Chairman, Lonza commented: Since announcing our intention to divest the Specialty Ingredients business, we have made significant progress in consolidating our new structure and identity and refining our focus as a pure-play partner to the healthcare industry. As the divestment of the Specialty Ingredients business completes, at Lonza we have an opportunity to consolidate our identity and redouble our focus on long-term growth while delivering value for our customers, employees and shareholders.
EQS-News: Lonza Completes Divestment of Specialty Ingredients Business
vom 02.07.2021, 07:00 Uhr
Bild: pixabay.com
Lonza Completes Divestment of Specialty Ingredients Business
02.07.2021 / 07:00
Basel, Switzerland, 2 July 2021 -
Lonza announced today the completion of the divestment of its former Specialty Ingredients business and operations to Bain Capital and Cinven for an enterprise value of CHF 4.2 billion.
Albert M. Baehny, Chairman, Lonza commented: Since announcing our intention to divest the Specialty Ingredients business, we have made significant progress in consolidating our new structure and identity and refining our focus as a pure-play partner to the healthcare industry. As the divestment of the Specialty Ingredients business completes, at Lonza we have an opportunity to consolidate our identity and redouble our focus on long-term growth while delivering value for our customers, employees and shareholders.
(2)
Lonza Signs Agreement to Divest Specialty Ingredients Business to Bain Capital and Cinven
Lonza Specialty Ingredients to be sold to Bain Capital and Cinven for an enterprise value of CHF 4.2 billion
Divestment will allow Lonza to refocus its business as a pure-play partner to the healthcare industry
Successful track record of investment in industrials sector and portfolio companies confirms that Bain Capital and Cinven are the right home for the business
Smooth transition for employees and customers is a priority for both seller and buyers. The transaction is anticipated to close in H2 2021
Quote from Albert Today s announcement is the result of a comprehensive and robust selection process.